United Kingdom· GB-APID-4040311000001101
Perdix 15mg tablets
A moexipril product containing moexipril, registered in United Kingdom by UCB Pharma Ltd. The same ATC class is registered in 3 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Moexipril is registered in 3 of 19 countries.
Countries holding a registration under ATC C09AA13 (moexipril), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 2 of them publish a price we can compare per daily dose
Moexipril · ATC C09AA13
3 / 19 countries
- Finlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Moexipril
- Manufacturer
- UCB Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- C09AA13
- ATC class
- Moexipril
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5015366085337
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
238 interactions on record for moexipril.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Moexipril · interactions on record
238 records
- 11 severe
- 164 moderate
- 17 minor
- 25 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
21 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Moexipril in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ee0b3e65-da47-4d6c-9884-87edd1e63258 GET /v1/drugs/ee0b3e65-da47-4d6c-9884-87edd1e63258?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4040311000001101",
"desc": "Perdix 15mg tablets (UCB Pharma Ltd)",
"form": "Oral tablet",
"vpid": "42377511000001103",
"source": "dmd",
"vtm_id": "776814005",
"strength": "15 mg",
"substance": "Moexipril",
"ingredient": "Moexipril hydrochloride",
"supplier_code": "2089701000001105"
}See everything about moexipril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.